Avascular necrosis of the bones: An overlooked complication of pulse steroid treatment of multiple sclerosis

European Journal of Neurology

Volumn 13, Issue 8, 2006, Pages 857-861

  Ce, Pinar ^a,c   Gedizlioglu, Muhtesem ^a   Gelal, Fazýl ^b   Coban, Pinar ^a   Ozbek, Gulriz ^a  

^a Izmir Ataturk Training and Research Hospital   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Avascular osteonecrosis; Multiple sclerosis; Pulse steroid treatment

Indexed keywords

METHYLPREDNISOLONE; STEROID;

ADULT; ALCOHOLISM; ARTICLE; AVASCULAR NECROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG ABUSE; ENTERITIS; FEMALE; FEMUR; HUMAN; MALE; MOBILIZATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEX; SICKLE CELL ANEMIA; THROMBOPHILIA;

ADULT; BODY MASS INDEX; CHOLESTEROL; COHORT STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; OSTEONECROSIS; TREATMENT OUTCOME;

EID: 33746430426     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01375.x     Document Type: Article

References (16)

1. Tullman MJ, Lublin FD, Miller AE. Immunotherapy of multiple sclerosis-current practice and future directions. Journal of Rehabilitation Research and Development 2002, 39: 273-286.
2. van Vugt RM, Sijbrandij ES, Bijlsma JW. Magnetic resonance imaging of the femoral head to detect avascular necrosis in active rheumatoid arthritis treated with methylprednisolone pulse therapy. Scandinavian Journal of Rheumatology 1996; 25: 74-76.
3. Stoller DW, Maloney WJ, Glick JM. The hip. In: Stoller DW, ed. Magnetic Resonance Imaging in Orthopedics and Sports Medicine. Philadelphia, PA: Lippincot Raven, 1997: 93-202.
4. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis and Rheumatism 1997; 40: 2055-2064.
5. Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clinical Reviews in Allergy and Immunology 2003; 25: 13-24.
6. Assouline-Dayan Y, Chang C, Greenspan A. Pathogenesis and natural history of osteonecrosis. Seminars in Arthritis and Rheumatism 2002; 32: 94-124.
7. Kisielinski K, Niedhart C, Schneider U, Niethard FU. Osteonecrosis 15 years after femoral neck fracture and long-term low-dose inhaled corticosteroid therapy. Joint Bone Spine 2004; 71: 237-239.
8. Nasser SMS, Ewan PW. Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. BMJ 2001; 322: 1589-1591.
9. McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. CMAJ 2001; 164: 205-206.
10. Migliaresi S, Picillo U, Ambrosone L, et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
11. Wing PC, Nance P, Connell DG, Gagnon F. Risk of avascular necrosis following short term megadose methylprednisolone treatment. Spinal Cord 1998; 36: 633-636.
12. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis and Rheumatism 2000; 43: 1801-1808.
13. Massardo E, Jacobelli S, Leissner M, Gonzales M, Villarroel L, Rivera S. High dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Lupus 1992; 1: 401-405.
14. Mok CC, Lau CS, Wong RWS. Risk factors for avascular bone necrosis in systemic lupus erythematosus. British Journal of Rheumatology 1998; 37: 895-900.
15. Zabinski SJ, Sculco TP, Dicarlo EF, Rivelis M. Osteonecrosis in the rheumatoid femoral head. Journal of Rheumatology 1998; 25: 1674-1680.
16. Mok MY, Farewell VT, Isenberg DA. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies? Annals of the Rheumatic Diseases 2000; 59: 462-467.